PGL
Click for more information
0.00% 44.5¢ prospa group limited.

lung cancer trial fails

  1. TobagoJack
    498 Posts.
    clock Created with Sketch.
    24/09/07
    11:19
    Post #: 2830254
    This company is now a one-trick pony, with superior drugs like Nexavar showing greater efficacy over a much wider range of conditions.

    Most analysts are rating this one a strong sell.
    PGL Price at posting: 0.0¢ Sentiment: Sell Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS HotCopper's top watched; Oz banks cut saver interest; Kamala’s 28% corporate tax; AI’s back
right-arrow Created with Sketch.
KPO KALiNA Power inks MOU for natgas powered data centres using carbon capture as AI energy use grows
right-arrow Created with Sketch.
NEWS The business of sport: Warren Tredrea's take on this week's news
right-arrow Created with Sketch.
NEWS Dale Gillham's weekly wrap: responding to a weak iron ore price with investing decisions
right-arrow Created with Sketch.
JAV Javelin increases the resource of Coogee in WA by 158%
right-arrow Created with Sketch.
RDN Raiden gears up for exploration in final quarter of 2024
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PGL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.